NO900484L - Fremgangsmaate for fremstilling av et nedbrytbart gemfibrozil-preparat. - Google Patents

Fremgangsmaate for fremstilling av et nedbrytbart gemfibrozil-preparat.

Info

Publication number
NO900484L
NO900484L NO90900484A NO900484A NO900484L NO 900484 L NO900484 L NO 900484L NO 90900484 A NO90900484 A NO 90900484A NO 900484 A NO900484 A NO 900484A NO 900484 L NO900484 L NO 900484L
Authority
NO
Norway
Prior art keywords
granulation
gemfibrozil
preparation
pharmaceutically acceptable
finely divided
Prior art date
Application number
NO90900484A
Other languages
English (en)
Norwegian (no)
Other versions
NO900484D0 (no
Inventor
Isaac Ghebre-Sellassie
Robert Harry Gordon
Sadath U Khan
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO900484D0 publication Critical patent/NO900484D0/no
Publication of NO900484L publication Critical patent/NO900484L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Dental Preparations (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
NO90900484A 1989-02-02 1990-02-01 Fremgangsmaate for fremstilling av et nedbrytbart gemfibrozil-preparat. NO900484L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/305,082 US4927639A (en) 1989-02-02 1989-02-02 Modified release gemfibrozil composition

Publications (2)

Publication Number Publication Date
NO900484D0 NO900484D0 (no) 1990-02-01
NO900484L true NO900484L (no) 1990-08-03

Family

ID=23179253

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90900484A NO900484L (no) 1989-02-02 1990-02-01 Fremgangsmaate for fremstilling av et nedbrytbart gemfibrozil-preparat.

Country Status (21)

Country Link
US (1) US4927639A (de)
EP (1) EP0381219B1 (de)
JP (1) JPH02240017A (de)
KR (1) KR0137268B1 (de)
CN (1) CN1053744A (de)
AT (1) ATE88889T1 (de)
AU (1) AU622751B2 (de)
CA (1) CA2009135A1 (de)
DE (1) DE69001488T2 (de)
DK (1) DK0381219T3 (de)
ES (1) ES2055177T3 (de)
FI (1) FI900491A0 (de)
HU (1) HU204192B (de)
IE (1) IE900371L (de)
IL (1) IL92994A (de)
MY (1) MY104898A (de)
NO (1) NO900484L (de)
NZ (1) NZ232321A (de)
PH (1) PH26317A (de)
PT (1) PT93029A (de)
ZA (1) ZA90776B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5331756A (en) * 1988-05-04 1994-07-26 Rehrig International, Inc. Basket wall with placard display assembly
EP0462067A1 (de) * 1990-06-15 1991-12-18 Warner-Lambert Company Gemfibrozil-Formulierung
EP0462066A1 (de) * 1990-06-15 1991-12-18 Warner-Lambert Company Amorphes Gemfibrozil
EP0475894A1 (de) * 1990-08-27 1992-03-18 Warner-Lambert Company Verbesserte Gemfibrozil-Formulierungen
US5102668A (en) * 1990-10-05 1992-04-07 Kingaform Technology, Inc. Sustained release pharmaceutical preparation using diffusion barriers whose permeabilities change in response to changing pH
SK282071B6 (sk) * 1991-01-30 2001-10-08 The Wellcome Foundation Limited Tableta dispergovateľná vo vode a spôsob jej prípravy
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
US5358723A (en) * 1991-11-26 1994-10-25 Warner-Lambert Company Process and composition for the development of controlled release gemfibrozil dosage form
EP0614358A1 (de) * 1991-11-26 1994-09-14 Warner-Lambert Company Verfahren und zusammensetzung für die entwicklung einer gemfibrozil dosierungsform mit kontrollierter freigabe
US5492700A (en) * 1991-11-26 1996-02-20 Warner-Lambert Company Process and composition for the development of controlled release gemfibrozil dosage form
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
DE4333190C2 (de) * 1993-09-29 1996-05-30 Korsatko Werner Univ Prof Dr E Zerbeißtablette mit verzögerter Wirkstoff-Freisetzung
US5451409A (en) * 1993-11-22 1995-09-19 Rencher; William F. Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
US6103262A (en) * 1994-01-27 2000-08-15 G. D. Searle & Company Modified-release metronidazole compositions and methods for making and using same
HU212428B (en) * 1994-05-13 1996-06-28 Egyt Gyogyszervegyeszeti Gyar Process to prepare pharmaceutical compositions containing gemfibrozyl
ES2262174T3 (es) * 1996-09-30 2006-11-16 Alza Corporation Forma de dosificacion y procedimiento de administracion de medicamentos.
EP1690531A3 (de) * 1996-09-30 2010-01-20 Alza Corporation Dosierungsform und Verfahren zur Verabreichung von einem Wirkstoff
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
US6814977B1 (en) 1998-12-18 2004-11-09 Abbott Laboratories Formulations comprising lipid-regulating agents
US7014864B1 (en) 1998-12-18 2006-03-21 Abbott Laboratories Formulations comprising lipid-regulating agents
US6838091B2 (en) 1998-12-18 2005-01-04 Abbott Laboratories Formulations comprising lipid-regulating agents
US6719999B2 (en) 1999-03-31 2004-04-13 Abbott Laboratories Formulations comprising lipid-regulating agents
US6465011B2 (en) 1999-05-29 2002-10-15 Abbott Laboratories Formulations comprising lipid-regulating agents
US6372251B2 (en) 1999-06-11 2002-04-16 Abbott Laboratories Formulations comprising lipid-regulating agents
TW200404544A (en) * 2002-06-17 2004-04-01 Kowa Co Controlled release pharmaceutical composition
US20050265955A1 (en) * 2004-05-28 2005-12-01 Mallinckrodt Inc. Sustained release preparations
CN1988884B (zh) * 2004-06-10 2013-01-02 格拉特气体技术公司 控制释放基质的药物剂型组成
FI125478B (fi) * 2010-03-30 2015-10-30 Pertti Neuvonen Farmaseuttinen koostumus, joka sisältää gemfibrotsiiliä ja CYP2C8- ja/tai OATP-substraattilääkettä
JP6364509B2 (ja) * 2014-09-22 2018-07-25 アンフェノール インターコン システムズ、インコーポレイテッド インターポーザ・アセンブリ及び方法
AU2021396978A1 (en) 2020-12-08 2023-02-23 Ruminant Biotech Corp Limited Improvements to devices and methods for delivery of substances to animals

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132753A (en) * 1965-02-12 1979-01-02 American Cyanamid Company Process for preparing oral sustained release granules
US4291016A (en) * 1976-07-27 1981-09-22 Sandoz Ltd. Enteric coated mixture of 4-(2-hydroxy-3-isopropylamino-propoxy) indole and sodium lauryl sulphate
US4195084A (en) * 1977-01-07 1980-03-25 Eli Lilly And Company Taste-stable aqueous pharmaceutical suspension of tall oil sitosterols and a method for the preparation thereof
IT1101649B (it) * 1978-12-15 1985-10-07 Lehner Ag Composizione farmaceutica ad azione prolungata contenente acidi biliari
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
JPS59193831A (ja) * 1983-04-18 1984-11-02 Sankyo Co Ltd 腸溶性製剤の製造法
HU190619B (en) * 1983-11-11 1986-09-29 Bezzegh,Denes,Hu Process for producing tablets with controlled dissolution of active ingredients
CH658188A5 (de) * 1984-03-23 1986-10-31 Ciba Geigy Ag Lagerstabile schnellzerfallende pharmazeutische presslinge.
JPS6144811A (ja) * 1984-08-10 1986-03-04 Ss Pharmaceut Co Ltd 徐放性ジクロフエナクナトリウム製剤
DE3678644D1 (de) * 1985-08-16 1991-05-16 Procter & Gamble Wirkstoffpartikel mit sowohl kontinuierlicher als auch schneller freisetzung.
US4778676A (en) * 1985-12-20 1988-10-18 Warner-Lambert Company Confectionery delivery system for actives
US4716033A (en) * 1986-03-27 1987-12-29 Warner-Lambert Company Medicament adsorbates with surfactant and their preparation
US4816264A (en) * 1986-06-06 1989-03-28 Warner-Lambert Company Sustained release formulations
IT1200178B (it) * 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
US4814354A (en) * 1986-09-26 1989-03-21 Warner-Lambert Company Lipid regulating agents
WO1988005296A2 (en) * 1987-01-27 1988-07-28 Warner-Lambert Company Lpid regulating compositions

Also Published As

Publication number Publication date
CN1053744A (zh) 1991-08-14
EP0381219A3 (en) 1990-12-05
HU900638D0 (en) 1990-04-28
NZ232321A (en) 1991-02-26
IL92994A (en) 1994-04-12
ES2055177T3 (es) 1994-08-16
FI900491A0 (fi) 1990-01-31
JPH02240017A (ja) 1990-09-25
HU204192B (en) 1991-12-30
US4927639A (en) 1990-05-22
DK0381219T3 (da) 1993-06-01
ZA90776B (en) 1991-10-30
PH26317A (en) 1992-04-29
CA2009135A1 (en) 1990-08-02
HUT52950A (en) 1990-09-28
DE69001488T2 (de) 1993-08-26
NO900484D0 (no) 1990-02-01
AU4899290A (en) 1990-08-09
EP0381219A2 (de) 1990-08-08
KR900012604A (ko) 1990-09-01
IE900371L (en) 1990-08-02
AU622751B2 (en) 1992-04-16
EP0381219B1 (de) 1993-05-05
ATE88889T1 (de) 1993-05-15
DE69001488D1 (de) 1993-06-09
PT93029A (pt) 1990-08-31
IL92994A0 (en) 1990-09-17
MY104898A (en) 1994-06-30
KR0137268B1 (ko) 1998-04-25

Similar Documents

Publication Publication Date Title
NO900484D0 (no) Fremgangsmaate for fremstilling av et nedbrytbart gemfibrozil-preparat.
EP0157695B1 (de) Feste Arzneimittel-Darreichungsformen mit gesteuerter Freisetzung auf Basis von Mischungen aus wasserlöslichen nichtionischen Celluloseethern und anionischen Tensiden
EP0322222B1 (de) Hydroxypropylmethylzellulose und Alkalimetall-Carboxylate enthaltende Arzneimittelverabreichungsformen mit verzögerter Freisetzung
US4540566A (en) Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
US3773920A (en) Sustained release medicinal composition
CA1188614A (en) Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
EP0324981B1 (de) Galenische Formulierungen mit gesteuerter Freigabe
CA1214391A (en) Long-acting matrix tablet formulations
US4849229A (en) Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
KR890001526A (ko) 경구용 서방성 아세트 아미노펜 제형 및 이의 제조방법
EP0108218A2 (de) Orale feste Verabreichungsform mit konstanter Wirkstoffabgabe pharmazeutischer Verbindungen, die sehr wasserlöslich sind
IL84167A0 (en) Compositions containing bioactive materials adapted for oral administration and methods for administration thereof
JPH0574568B2 (de)
EP0274845A1 (de) Ibuprofen und Codein enthaltende, stabile, feste Arzneimittel
GEP20033078B (en) Controlled-Release Compositions of Betahistine
CA2361496A1 (en) Ph independent extended release pharmaceutical formulation
JPS5781409A (en) External plaster
EP0519371B1 (de) Feste, stabilisierte Arzneimittelform von Choline-Metall-Carboxymethylzellulose-Salicylat enthaltenden Zusammensetzungen
JPH11286438A (ja) 徐放性製剤
AU609234B2 (en) Sustained release drug dosage forms containing hydroxypropylmethylcellulose and alkali metal carboxylates
HU215191B (hu) Eljárás Levodopa és Carbidopa hatóanyag-kombinációt tartalmazó, szabályozott hatóanyag-leadású, központi dopaminhiányos állapotok kezeléséhez alkalmas orális gyógyszerkészítmény előállítására
GB1570994A (en) Pharmaceutical formulation